Cancer Detection AI built for pathologists who want efficient diagnostics
for faster, more accurate cancer detection.
Predictions indicate that the number of new cancer cases will reach 35 million by 2050 (77% increase)*
With pathologists responsible for diagnosing 100% of all cancers, their workloads are set to increase.
Franklin.ai leverages cutting-edge technology to transform AI Cancer Detection and streamline cancer diagnostics. Its advanced capabilities are especially impactful in the AI detection of prostate cancer. Franklin's AI Cancer Detection AI includes two products designed to support both traditional histopathology workflows and digital pathology systems.
Franklin.ai Digital integrates seamlessly with digital pathology workflows, analysing whole-slide images to identify and flag clinically significant abnormalities. Franklin.ai Glass integrates with traditional histopathology workflows, bringing the power of AI to glass slides without the need for digital scanners.
Designed to support pathologists in managing rising caseloads, Franklin.ai’s Cancer Detection AI models analyse prostate core biopsies (PCB) and TURP chips with exceptional precision. Franklin.ai achieved near-perfect or substantial agreement in significant clinical findings across 1,735 slides reviewed by a panel of 12 subspecialists. By automating routine tasks, flagging areas of concern, and pre-populating reports, Franklin.ai enables pathologists to focus their expertise on complex cases, navigate workloads more efficiently, and deliver timely, confident diagnoses.
Our Cancer Detection AI is designed to assist pathologists in diagnosing a variety of cancer types with speed and precision. By analysing whole-slide images or traditional glass slides, our technology identifies key clinical findings, ensuring that no detail is overlooked.
This adaptable approach supports pathologists in delivering timely and accurate cancer diagnoses across different tissue types, helping to address rising caseloads and improve patient care outcomes. Whether working with complex cases or routine screenings, Franklin.ai's advanced AI that detects cancer enhances diagnostic workflows at every stage.
Franklin.ai’s cancer detecting AI tools provide pathologists with AI-driven insights, highlighting areas of concern and streamlining case reviews. This reduces diagnostic uncertainty and allows healthcare professionals to focus on delivering high-quality patient care.
By integrating cancer detection AI into workflows, Franklin.ai automates routine tasks and pre-populates reports with clinically significant findings, enabling pathologists to allocate more time to complex cases. Our cancer detection AI enhances efficiency and supports laboratories in managing increasing workloads without compromising care standards.
Whether your lab is fully digital or still using glass slides, Franklin.ai’s cancer detection AI is designed to be plug and play. Our platform works with digital pathology and traditional microscopy so you can use it in any lab.
By helping identify malignant features and triage high risk cases, our AI allows pathologists to prioritise complex slides while maintaining diagnostic accuracy at high volumes. This reduces variability, speeds up turnaround times and helps with the pressure of increasing caseloads – especially in high throughput or resource constrained labs.
Franklin.ai’s deep learning models are trained on real world, expert annotated pathology data to give consistent, evidence based results. Whether used in digital workflows through whole slide imaging or as a decision support tool in glass slide interpretation, our AI for cancer diagnosis helps pathology teams work more efficiently without compromising accuracy.
As pathology services get busier, our AI driven cancer detection is a scalable solution – improving quality, reproducibility and confidence in everyday diagnosis.
Schedule a call with our team to explore how Franklin.ai can revolutionise your lab’s workflow. Lab directors can optimise operational efficiency, while pathologists benefit from advanced cancer detection AI support tailored to prostate cancer diagnostics.